These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 7954759

  • 1. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice.
    Russell MB, Holm-Thomsen OE, Rishøj Nielsen M, Cleal A, Pilgrim AJ, Olesen J.
    Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759
    [Abstract] [Full Text] [Related]

  • 2. [Sumatriptan treatment of migraine in general practice. A randomized, double-blind, placebo-controlled cross-over study].
    Russell MB, Holm-Thomsen OE, Nielsen MR, Cleal A, Pilgrim AJ, Olesen J.
    Ugeskr Laeger; 1995 Apr 17; 157(16):2320-3. PubMed ID: 7652970
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT, Landy S, Stark S, Tietjen GE, Derosier FJ, White J, Lener SE, Bukenya D.
    Headache; 2009 Jul 17; 49(7):971-82. PubMed ID: 19486178
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group.
    Bousser MG, D'Allens H, Richard A.
    J Intern Med; 1993 Aug 17; 234(2):211-6. PubMed ID: 8393474
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.
    Cady RK, Munjal S, Cady RJ, Manley HR, Brand-Schieber E.
    J Headache Pain; 2017 Dec 17; 18(1):17. PubMed ID: 28176235
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group.
    Diener HC.
    Cephalalgia; 1999 Jul 17; 19(6):581-8; discussion 542. PubMed ID: 10448545
    [Abstract] [Full Text] [Related]

  • 11. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS.
    Clin Ther; 2005 Apr 17; 27(4):407-17. PubMed ID: 15922814
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G, Blumenthal H, Webster CJ, Richardson MS, Ames M.
    Clin Ther; 2007 Jan 17; 29(1):99-109. PubMed ID: 17379050
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study.
    Landy S, Munjal S, Brand-Schieber E, Rapoport AM.
    J Headache Pain; 2018 Aug 15; 19(1):69. PubMed ID: 30112726
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study.
    Landy S, Munjal S, Brand-Schieber E, Rapoport AM.
    J Headache Pain; 2018 Aug 15; 19(1):70. PubMed ID: 30112725
    [Abstract] [Full Text] [Related]

  • 16. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May 15; 19(4):232-40. PubMed ID: 10376168
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R, Elkind A, Baker CC, Mullican W, DeBussey S, Asgharnejad M.
    Neurology; 1997 Nov 15; 49(5):1225-30. PubMed ID: 9371898
    [Abstract] [Full Text] [Related]

  • 19. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
    Solbach MP, Waymer RS.
    Obstet Gynecol; 1993 Nov 15; 82(5):769-72. PubMed ID: 8414324
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.